thanks for your support
The Cloudmaker Whiteout DNA, the second configuration of Cloudmaker Tech’s modular, future-proof, user-customizable personal vaporizer. The Whiteout DNA unit comes fully-assembled & QC-tested with Evolv’s cutting-edge new customizable DNA200 Temperature Control chipset. The DNA200 can push up to 200W using a 1100mAh 3S LiPo battery configuration, and we are working on offering a 1300mAh expansion kit! The genius of the Whiteout is that you can interchange and customize every part of it, from changing the color and material of your device’s panels, to upgrading/swapping your chip itself without soldering or special skills. This future-proof flexibility is thanks to our modular design & specially-developed Build Kits, which are based on community requests and released regularly to expand the possible factory-supported configurations of the Whiteout.
Evolv DNA 200
200 Watt Variable Power Module with Temperature Protection and USB The DNA 200 is a power regulated digital switch-mode DC-DC converter for personal vaporizers. It features Evolv’s patented Wattage Control, Temperature Protection, Preheat, OLED Screen, and waterproof onboard buttons. The USB port and Evolv’s EScribe software can be used to customize or monitor the user experience. The DNA 200 runs from a 3 cell lithium polymer battery, and features cellby-cell battery monitoring and integrated 1A balance charger. It is the most advanced personal vaporizer controller ever made.
E-cigarettes: an emerging public health consensus
Joint statement on e-cigarettes by Public Health England and other UK public health organisations.
We all agree that e-cigarettes are significantly less harmful than smoking. One in 2 lifelong smokers dies from their addiction. All of the evidence suggests that the health risks posed by e-cigarettes are relatively small by comparison but we must continue to study the long term effects.
And yet, millions of smokers have the impression that e-cigarettes are at least as harmful as tobacco and we have a responsibility to provide clear information on the facts as we know them to be. It is our duty to provide reassurance for the 1.1 million e-cigarette users who have completely stopped smoking to prevent their relapse.
To be clear, the public health opportunity is in helping smokers to quit, so we may encourage smokers to try vaping but we certainly encourage vapers to stop smoking tobacco completely.
We know that e-cigarettes are the most popular quitting tool in the country with more than 10 times as many people using them than using local stop smoking services. But, we also know that using local stop smoking services is by far the most effective way to quit.
What we need to do is combine the most popular method with the most effective and that is why we are encouraging those who want to use e-cigarettes to quit smoking to seek the help of their local stop smoking service.
The current national evidence is that in the UK regular e-cigarette use is almost exclusively confined to those young people who smoke, and youth smoking prevalence is continuing to fall. This is an area that we will continue to research and keep under closest surveillance. In October this year, regulations to protect children will make it an offence to sell e-cigarettes to anyone under 18 or to buy e-cigarettes for them and within a year the EU Tobacco Products Directive proposes a ban on all print and broadcast advertising of e-cigarettes as part of a full range of regulations.
We should not forget what is important here. We know that smoking is the number one killer in England and we have a public health responsibility to provide smokers with the information and the tools to help them quit smoking completely and forever.
PHE has always been very clear on its commitment to providing up to date information on the emerging evidence on e-cigarettes, as shown in the recent review which is the third in this area in the last 2 years. This commitment drove PHE and Cancer Research UK to set up the UK E-cigarette Research Forum. PHE is honouring its longstanding promise to monitor and share the evidence, providing clear messages to the public.
There is no circumstance in which it is better for a smoker to continue smoking – a habit that kills 1 in every 2 and harms many others, costing the NHS and society billions every year. We will continue to share what we know and address what we don’t yet know, to ensure clear, consistent messages for the public and health professionals.
Public Health England
Action on Smoking and Health
Association of Directors of Public Health
British Lung Foundation
Cancer Research UK
Faculty of Public Health
Fresh North East
Public Health Action (PHA)
Royal College of Physicians
Royal Society for Public Health
Tobacco Free Futures
UK Centre for Tobacco and Alcohol Studies
UK Health Forum
Public Health England press office
Telephone 020 7654 8400
Out of hours telephone 020 8200 4400
Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It does this through world-class science, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. PHE is an operationally autonomous executive agency of the Department of Health. Website: www.gov.uk/phe. Twitter: @PHE_uk, Facebook: www.facebook.com/PublicHealthEngland
Published:15 September 2015